Clinical Trials Directory

Trials / Completed

CompletedNCT03385850

The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis

The Roles of Th17/Treg Cells and IL-23/IL-17 Axis in the Mechanisms of Early Enteral Nutrition Improving Immune Function of Sepsis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Nanjing First Hospital, Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to evaluate the roles of Th17/Treg cells and IL-23/IL-17 axis in the mechanisms of early enteral nutrition (EEN) correcting immune imbalance of sepsis by means of improving the intestinal flora disturbance. The results of this study would lay the foundation for revealing the mechanisms of EEN improving immune imbalance of sepsis and provide a new idea to the early treatment of sepsis

Conditions

Interventions

TypeNameDescription
OTHERenteral nutritionearly enteral nutrition group or delayed enteral nutrition group

Timeline

Start date
2017-10-01
Primary completion
2018-06-30
Completion
2018-12-31
First posted
2017-12-29
Last updated
2019-03-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03385850. Inclusion in this directory is not an endorsement.

The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis (NCT03385850) · Clinical Trials Directory